Tirzepatide is a cutting-edge dual GIP/GLP-1 receptor stimulator. This medication has shown exceptional results in clinical trials for the treatment of type 2 diabetes. By activating both the GIP and GLP-1 receptors, https://zakariabqcs578053.aboutyoublog.com/51448176/tirzepatide-a-promising-novel-agent-for-diabetes